The devil is always in the details. So it all depends on what one means by "FDA reform." If it means, for instance, hiring more qualified FDA reviewers, I think most of us would see this as a good thing. If "FDA reform" means instituting the ideas in McClellan's "Critical Path Initiative," then that would also be a good thing, IMO.
So let's wait a bit and see what the details are of any FDA reform plan.